Overall survival benefit for sequential doxorubicin–docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer—8-year results of the Breast International Group 02-98 phase III trial†
about
Adjuvant chemotherapy for early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guidelineSynthetic lethality in lung cancer and translation to clinical therapiesPrognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial.Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis.Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses.Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells.Forty years of landmark trials undertaken by the Danish Breast Cancer Cooperative Group (DBCG) nationwide or in international collaboration.Sequential vs concurrent epirubicin and docetaxel as adjuvant chemotherapy for high-risk, node-negative, early breast cancer: an interim analysis of a randomised phase III study from the Hellenic Oncology Research Group.
P2860
Q26853619-5C1DBA58-C5FD-44B4-953A-F08AD02FBBF9Q28072904-235B0210-EE75-4172-899D-BBCE4AC048C2Q36245341-B1B55430-1D03-4E4B-B883-1841A7276DD7Q36414347-58438F34-7EA9-4440-A3C3-BCC78C2A0FD9Q37113312-8731D505-D764-480F-ACF3-FFCE1F64CA2EQ37697134-68D1CE25-3513-468C-80E8-0B5B28CCB6C7Q47368780-07103466-EECF-4F29-AEBB-3E7676E3367CQ51841285-163E0672-C972-423F-8E8C-30BB2A773D37
P2860
Overall survival benefit for sequential doxorubicin–docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer—8-year results of the Breast International Group 02-98 phase III trial†
description
im Januar 2013 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 04 January 2013
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2013
@uk
name
Overall survival benefit for s ...... l Group 02-98 phase III trial†
@en
Overall survival benefit for s ...... l Group 02-98 phase III trial†
@nl
type
label
Overall survival benefit for s ...... l Group 02-98 phase III trial†
@en
Overall survival benefit for s ...... l Group 02-98 phase III trial†
@nl
prefLabel
Overall survival benefit for s ...... l Group 02-98 phase III trial†
@en
Overall survival benefit for s ...... l Group 02-98 phase III trial†
@nl
P2093
P2860
P50
P356
P1433
P1476
Overall survival benefit for s ...... al Group 02-98 phase III trial
@en
P2093
B Nordenskjöld
B Thürlimann
D Larsimont
I Steinberg
J Gutiérrez
L Punzalan
P2860
P304
P356
10.1093/ANNONC/MDS627
P577
2013-01-04T00:00:00Z